1257250-52-4Relevant articles and documents
CINNOLINE DERIVATIVES AS AS BTK INHIBITORS
-
, (2013/10/21)
Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined in the specification. The compounds are inhibitors of Bruton's tyrosine
PROTEIN KINASE INHIBITORS
-
Page/Page column 41, (2010/11/28)
Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.